Istanbul, Turkey

Dilek Telci Temeltas

This inventor holds 1 USPTO granted patent. Top assignee: Yeditepe Üniversitesi. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dilek Telci Temeltas. Retrieved from https://idiyas.com/inventor/dilek-telci-temeltas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dilek Telci Temeltas and Research on Endometriosis Biomarkers.

Introduction

Dilek Telci Temeltas is an inventor based in Istanbul, Türkiye, whose patent work focuses on potential biological markers for diagnosing endometriosis. She is affiliated with Yeditepe University.

Latest Patents

Temeltas is associated with 1 patent, titled “Biological Markers in the Diagnosis of Endometriosis.” The invention describes combinations of biological markers that may help distinguish endometriosis from healthy conditions by identifying differences in markers expressed in endometrial mesenchymal stem cells (eMSCs). It identifies tissue transglutaminase as a potential biomarker in eMSCs obtained from endometrial biopsy samples and/or menstrual blood from patients with endometriosis.

Career Highlights

The patent reflects Temeltas’s contribution to research into diagnostic approaches for endometriosis, including the investigation of biological markers in cells derived from endometrial samples.

Collaborations

Her listed coworkers include Inci Kurt Celep and Melike Batukan. Her work is associated with Yeditepe University.

Conclusion

Dilek Telci Temeltas’s patent centers on tissue transglutaminase and other biological markers as potential tools for diagnosing endometriosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…